Showing 1 - 1 of 1 results
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Conditions:
Fidarestat (SNK-860) is an aldose reductase inhibitor codeveloped by Sanwa Kagaku, NK Curex, and Sankyo for the treatment of distal symmetric polyneuropathy (DSP). In a Phase III trial, 279 patients with DSP were randomized to receive fidarestat (1 m...